Lv3
400 积分 2025-11-01 加入
A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement
3个月前
已关闭
A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia
3个月前
已完结
Optimizing the Design and Geometry of T Cell-Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
3个月前
已完结
IBI379, a novel B cell maturation antigen/CD3 bispecific T-cell engager, displays high antitumor efficacy in preclinical models of multiple myeloma
3个月前
已完结
P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A
3个月前
已完结
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors
3个月前
已完结
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice
3个月前
已完结
Target-independent Immune-cell Activation by Aggregates of T Cell-redirecting Bispecific Antibodies
3个月前
已完结
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3
3个月前
已关闭
An Anti-EGFR/anti- HER2 Bispecific Antibody with Enhanced Antitumor Activity Against Acquired Gefitinib-Resistant NSCLC Cells
3个月前
已完结
皖公网安备34019202002308
